Prosecution Insights
Prosecution Insights
Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Mega Crystal Biotechnology Singapore Pte. Ltd. has 1 pending office action in the Semiconductors, Circuits & Optics technology area. This action is handled by 1 distinct examiner. The prosecution is conducted within 1 distinct art unit. This 1 pending office action represents the entirety of the company's active prosecution in this technical field.
AKANBI, ISIAKA O is the busiest examiner for this portfolio, responsible for the 1 pending office action currently on record. Because there is only 1 distinct examiner, there is no variation in the personnel reviewing the company's work. The 1 action assigned to AKANBI, ISIAKA O is the sole focus of the company's current prosecution efforts. Practitioners can concentrate their resources on this single matter within the Semiconductors, Circuits & Optics area.
The concentration in 1 distinct art unit and with 1 distinct examiner indicates a specific technical focus for the company's work. Since AKANBI, ISIAKA O is the only individual involved, the company's results depend entirely on this single review. The 1 distinct art unit provides the administrative context for this isolated prosecution effort. This 1 pending office action serves as the primary indicator of the company's current progress at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AKANBI, ISIAKA O | 1 | 76.6% | +22.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19196752 | LIGHT-EMITTING DEVICE, LIGHT DETECTION DEVICE AND METHOD FOR OPTICAL ANALYSIS | AKANBI, ISIAKA O | — |
| Art Unit | Apps |
|---|---|
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19196752 | LIGHT-EMITTING DEVICE, LIGHT DETECTION DEVICE AND METHOD FOR OPTICAL ANALYSIS | AKANBI, ISIAKA O | 2877 | §102 | Non-Final OA | — | Pending | May 02, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMega Crystal Biotechnology Singapore Pte. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Isiaka O Akanbi has the most, with 1 of Mega Crystal Biotechnology Singapore Pte. Ltd.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.